about
Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF.Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.Optimization of humanized IgGs in glycoengineered Pichia pastoris.Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastorisProduction of monoclonal antibodies by glycoengineered Pichia pastoris
P50
Q33325527-87B2349F-EC38-43E9-A7A6-8805E938B99CQ33416895-DF0646D4-939B-4319-94FE-31A73D858380Q39559611-1FC077FA-6A2D-4FA1-BE04-698CA077639EQ51284070-484A3842-74EF-40D8-B150-F3080FF49744Q51756891-B9B635AE-FF60-4D7E-9F84-54722CF00848Q82444212-1CC9E6CC-4430-48D6-AD82-1BAB8C7DE13EQ83222870-E062DEE8-F49D-413B-B139-652FBE351B4E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Cukan
@ast
Michael Cukan
@en
Michael Cukan
@es
Michael Cukan
@nl
type
label
Michael Cukan
@ast
Michael Cukan
@en
Michael Cukan
@es
Michael Cukan
@nl
prefLabel
Michael Cukan
@ast
Michael Cukan
@en
Michael Cukan
@es
Michael Cukan
@nl
P106
P31
P496
0000-0002-7376-0428